PolyPeptide Group AG
SIX:PPGN

Watchlist Manager
PolyPeptide Group AG Logo
PolyPeptide Group AG
SIX:PPGN
Watchlist
Price: 27.4 CHF 0.55%
Market Cap: 903.8m CHF
Have any thoughts about
PolyPeptide Group AG?
Write Note

PolyPeptide Group AG
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PolyPeptide Group AG
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
PolyPeptide Group AG
SIX:PPGN
Income from Continuing Operations
-€51.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Income from Continuing Operations
CHf113.6m
CAGR 3-Years
5%
CAGR 5-Years
18%
CAGR 10-Years
16%
Siegfried Holding AG
SIX:SFZN
Income from Continuing Operations
CHf128.8m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Income from Continuing Operations
CHf574m
CAGR 3-Years
4%
CAGR 5-Years
-2%
CAGR 10-Years
12%
Tecan Group AG
SIX:TECN
Income from Continuing Operations
CHf101.3m
CAGR 3-Years
-12%
CAGR 5-Years
9%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Income from Continuing Operations
CHf27.9m
CAGR 3-Years
34%
CAGR 5-Years
37%
CAGR 10-Years
N/A
No Stocks Found

PolyPeptide Group AG
Glance View

Market Cap
903.8m CHF
Industry
Life Sciences Tools & Services

PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.

PPGN Intrinsic Value
25.14 CHF
Overvaluation 8%
Intrinsic Value
Price

See Also

What is PolyPeptide Group AG's Income from Continuing Operations?
Income from Continuing Operations
-51.4m EUR

Based on the financial report for Dec 31, 2023, PolyPeptide Group AG's Income from Continuing Operations amounts to -51.4m EUR.

Back to Top